Q2 2020

Source filing unavailable

Q2 2020 · —

Revenue—

Net Income

-$5.87M

N/M vs Q2 2019

EPS Diluted

-$6.79

no prior Q2 2019 on file

Operating Income-$6,040,000—

Operating Cash Flowderived-$6,222,000—

Free Cash Flowderived

Same quarter

Metric	Q2 2020	Q2 2019
Net Income	-$5.87M	-$10.26M
EPS Diluted	-$6.79	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

CalciMedica, Inc. · CIK 1534133 · Engraved from SEC EDGAR